BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25339434)

  • 21. Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement.
    Gibelin A; Maldini C; Mahr A
    Semin Respir Crit Care Med; 2011 Jun; 32(3):264-73. PubMed ID: 21674413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
    Craven A; Robson J; Ponte C; Grayson PC; Suppiah R; Judge A; Watts R; Merkel PA; Luqmani RA
    Clin Exp Nephrol; 2013 Oct; 17(5):619-621. PubMed ID: 23996327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
    Seeliger B; Sznajd J; Robson JC; Judge A; Craven A; Grayson PC; Suppiah RS; Watts RA; Merkel PA; Luqmani RA
    Rheumatology (Oxford); 2017 Jul; 56(7):1154-1161. PubMed ID: 28379475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic vasculitis.
    Sharma P; Sharma S; Baltaro R; Hurley J
    Am Fam Physician; 2011 Mar; 83(5):556-65. PubMed ID: 21391523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of vasculitides: differences between Japan, Europe and North America.
    Kobayashi S; Fujimoto S
    Clin Exp Nephrol; 2013 Oct; 17(5):611-614. PubMed ID: 23715862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.
    Berti A; Caporali R; Montecucco C; Paolazzi G; Monti S
    Drugs Aging; 2019 Jan; 36(1):53-63. PubMed ID: 30484240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new algorithm in classification of systemic vasculitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Rheumatology (Oxford); 2008 May; 47(5):708-12. PubMed ID: 18390585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021.
    Henes J; Richter JG; Thiele K; Kiltz U; Callhoff J; Albrecht K
    Rheumatol Int; 2024 Mar; 44(3):497-507. PubMed ID: 38180499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and classification criteria of Takayasu arteritis.
    de Souza AW; de Carvalho JF
    J Autoimmun; 2014; 48-49():79-83. PubMed ID: 24461381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of systemic vasculitis.
    Ozguler Y; Esatoglu SN; Hatemi G
    Curr Opin Rheumatol; 2024 Jan; 36(1):21-26. PubMed ID: 37800639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
    Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
    Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of the vasculitides.
    Watts RA; Scott DG
    Semin Respir Crit Care Med; 2004 Oct; 25(5):455-64. PubMed ID: 16088491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-systemic Vasculitic Neuropathy].
    Koike H
    Brain Nerve; 2016 Mar; 68(3):233-41. PubMed ID: 27001772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
    Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
    Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.